Skip to main content

Table 1 Inclusion and exclusion criteria for donors

From: Thrombin based gelatin matrix and fibrin sealant mediated clot formation in the presence of clopidogrel

Inclusion criteria for clopidogrel donors

Inclusion criteria for age matched control donors

Exclusion criteria

Clopidogrel or clopidogrel and aspirin use for at least 14 days prior to blood draw

No clopidogrel use for at least 14 days prior to blood draw

History of diabetes, renal failure, acute or chronic liver disease, including acute or chronic hepatitis or cirrhosis

If on aspirin, daily aspirin dosage of at least 75 mg/day

No aspirin use for at least 14 days prior to blood draw

Positive for HIV, hepatitis B, or hepatitis C

Males and Females

Males and Females

Use of Selective Serotonin Re-uptake Inhibitors (SSRIs), Seritonin-Norepinepherin Re-uptake Inhibitors (SNRIs), Omeprazole (which interferes with clopidogrel metabolism) [25], or oral anticoagulants (Coumadin, Warfarin, etc.)